Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.
Aera Therapeutics has raised $193.0M in total funding. The most recent round was Series B. The last funding was announced in February 2023.
Aera Therapeutics's investors include ARCH Venture Partners, Lux Capital, Google Ventures.
Aera Therapeutics is headquartered in Boston, United States.
Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.
Aera Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aera Therapeutics — Funding & Investors." VCBacked, February 16, 2023, https://www.vcbacked.co/company/aera-therapeutics. Accessed July 19, 2026.
VCBacked. (2023). Aera Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/aera-therapeutics
{{cite web |title=Aera Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aera-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated